Related Experiment Video
Updated: Apr 25, 2026

Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
Prognostic value of cardiopulmonary exercise testing parameters in young heart failure patients with moderately
Shotaro Komeyama1,2, Osamu Seguchi1,3, Makoto Murata4
1Department of Transplant Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan.
Insights
Cardiopulmonary exercise testing (CPET) helps predict prognosis in young heart failure (HF) patients. A ventilatory efficiency (VE/VCO2) slope of 31 or higher indicates increased risk for major adverse cardiovascular events (MACE) within one year.
Area of Science:
- Cardiology
- Exercise Physiology
Background:
- Cardiopulmonary exercise testing (CPET) is crucial for prognosis in ambulatory heart failure (HF) patients.
- Interpreting CPET in young HF patients (≤50 years) presents unique challenges due to their generally optimistic outlook.
- This study focuses on the prognostic value of CPET parameters in this specific demographic.
Purpose of the Study:
- To evaluate the clinical impact of CPET parameters in predicting the prognosis of young, ambulatory HF patients.
- To identify key CPET metrics associated with major adverse cardiovascular events (MACE) within one year.
- To establish optimal thresholds for CPET parameters in risk stratification for young HF patients.
Main Methods:
- A retrospective observational study involving 113 young (≤50 years) HF patients with reduced ejection fraction (≤40%) and peak oxygen uptake (VO2) ≥12 mL/kg/min.
- Primary endpoint: occurrence of MACE (death, HF admission, fatal arrhythmia) within 1 year post-CPET.
- Statistical analyses included multivariate Cox regression and receiver operating characteristic (ROC) curve analysis.
Main Results:
- 39.8% of patients experienced MACE within one year.
- Multivariate analysis identified age, brain natriuretic peptide, serum creatinine, and ventilatory efficiency (VE/VCO2 slope) as significant predictors of MACE.
- ROC analysis determined a VE/VCO2 slope of 31 as the optimal cutoff for predicting prognosis.
Conclusions:
- Nearly 40% of young HF patients with moderate exercise capacity face MACE within a year.
- A VE/VCO2 slope ≥31 in young HF patients signals a need for closer monitoring and potential consideration for advanced therapies.
- CPET parameters, particularly the VE/VCO2 slope, are valuable tools for risk-stratifying young ambulatory HF patients.
Background:
Exercise capacity, evaluated using cardiopulmonary exercise testing (CPET), is an important prognostic factor in ambulatory heart failure (HF) patients. However, interpreting the results of CPET in young, ambulatory HF patients who tend to be optimistic about their prognosis is complicated. This study aimed to assess the clinical impact of CPET parameters in predicting the prognosis of young, ambulatory HF patients.
Methods:
This single-center retrospective observational study targeted young (≤50 years) HF patients with reduced ejection fraction (left ventricular ejection fraction ≤40%) and peak oxygen uptake (VO2) ≥12 mL/kg/min. The primary endpoint was occurrence of major adverse cardiovascular events (MACE), such as death, admission for HF, and fatal arrhythmia, within 1 year after CPET.
Results:
A total of 113 patients (median age, 43 [35-47] years) were enrolled: of these, 45 (39.8%) experienced MACE (death, n = 2; admission for HF, n = 35; fatal arrhythmia, n = 8). Multivariate Cox regression analysis demonstrated age, plasma brain natriuretic peptide level, serum creatinine level, and ventilatory efficiency (VE/VCO2 slope) were associated with the occurrence of MACE within 1 year after CPET. Receiver operating characteristic curve analysis revealed a VE/VCO2 slope of 31 was the optimal cutoff value for predicting prognosis.
Conclusions:
Nearly 40% of young (≤50 years) HF patients with moderately reduced exercise capacity (peak VO2 ≥12 mL/kg/min) experienced MACE within 1 year after CPET. Among these patients, those with a VE/VCO2 slope ≥31 may warrant earlier consideration for left ventricular assist devices or heart transplantation.
More Related Videos
Related Concept Videos
Exercise Stress Test
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Cardiomyopathy II: Dilated Cardiomyopathy
Pathophysiology of Heart Failure
Heart Failure VII: Nursing Interventions

